Jounce Therapeutics

Jounce Therapeutics is dedicated to transforming the treatment of cancer

Jounce is discovering and developing novel cancer immunotherapies designed to mobilize the immune system to seek out and attack cancerous cells and tumors. Jounce's proprietary product engine has the potential to discover novel biological insights to drive the development of game-changing immunotherapy treatments with highly durable responses, extending and improving patients' quality of life.

Jounce News


Jounce Therapeutics to Present at the Cowen and Company 35th Annual Health Care Conference

Read More > >


Jounce Therapeutics Appoints Deborah Law, D. Phil., to Chief Scientific Officer

Read More > >


Jounce Therapeutics to Present at the J.P. Morgan Healthcare Conference

Read More > >